代表性论文
1. Z. Xie, Z. Meng, X. Yang, Y. Duan, Q. Wang*, C. Liao*, Factor XIa Inhibitors in Anticoagulation Therapy: Recent Advances and Perspectives, J Med Chem, 2023, online.
2. Z. Xie, S. Hou, X. Yang, Y. Duan, J. Han, Q. Wang*, C. Liao*, Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts, J Med Chem, 2022, 65, 6356-6389.
3. Z. Xie, X. Yang, Y. Duan, J. Han, C. Liao*, Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases, J Med Chem, 2021, 64, 1283-1345.
4. N. Yao, Z. Jia, Y. Tian, S. Hou, X. Yang, J. Han, Y. Duan, C. Liao*, Y. Kong*, Z. Xie*, Targeting the S2 Subsite Enables the Structure-Based Discovery of Novel Highly Selective Factor XIa Inhibitors, J Med Chem, 2022, 65, 4318-4334.
5. L. Zhang, W. Chen, N. Yao, S. Hou, Z. Meng, Y. Kong, C. Liao*, Z. Xie*. Discovery of novel aspartate derivatives as highly potent and selective FXIa inhibitors, J Chin Pharm Sci, 2022, 31, 727-737.
6. R. Hou, Y. He, G. Yan, S. Hou, Z. Xie*, C. Liao*, Zinc enzymes in medicinal chemistry, Eur J Med Chem, 2021, 226, 113877.
7. Z. Xie*, Z. Li, Y. Shao, C. Liao*, Discovery and development of plasma kallikrein inhibitors for multiple diseases, Eur J Med Chem, 2020, 190, 112137.
8. X. Lv, Y. Tian, S. Li, K. Cheng, X. Huang, H. Kong, C. Liao*, Z. Xie*, Discovery and Development of Cyclin-Dependent Kinase 8 Inhibitors, Curr Med Chem, 2020, 27, 5429-5443.
9. S. Li, X. Lv, K. Cheng, Y. Tian, X. Huang, H. Kong, Y. Duan, J. Han, C. Liao*, Z. Xie*, Discovery of novel 2,3-dihydro-1H-inden-1-amine derivatives as selective monoamine oxidase B inhibitors, Bioorg Med Chem Lett, 2019, 29, 1090-1093.
10. Z. Xie*, Y. Tian, X. Lv, X. Xiao, M. Zhan, K. Cheng, S. Li, C. Liao*, The selectivity and bioavailability improvement of novel oral anticoagulants: An overview, Eur J Med Chem, 2018, 146, 299-317.
